Literature DB >> 24106117

Relationship between retinal layer thickness and focal macular electroretinogram components after epiretinal membrane surgery.

Nobuaki Hibi1, Shinji Ueno, Yasuki Ito, Chang-Hua Piao, Mineo Kondo, Hiroko Terasaki.   

Abstract

PURPOSE: To study the effect of epiretinal membrane (ERM) removal on the function and structure of the retina, and to determine whether the functional changes were correlated with the changes in the thickness of different retinal layers.
METHODS: Focal macular electroretinography (FMERG) and spectral-domain optical coherence tomography (SD-OCT) were performed on 17 eyes of 15 patients before and after ERM surgery. The parafoveal retina was divided into an inner layer, a middle layer, and an outer layer in the OCT images. The thickness of each layer was measured before and after the ERM surgery. The a-wave, b-wave, and oscillatory potentials (OPs) of the FMERGs were analyzed before and after the ERM surgery.
RESULTS: The thickness of the inner and middle retinal layers was significantly reduced after surgery (by 39% and 23%, respectively). The mean amplitudes of the b-waves and OPs at 6 months postoperatively were significantly larger than those recorded preoperatively (by 21% and 61%, respectively). The ratios of the pre- to postoperative b-wave and OP amplitudes were correlated with the thickness reduction of the middle retinal layer (b-wave, r = -0.51, P < 0.05; OPs, r = -0.82, P < 0.01).
CONCLUSIONS: The significant correlations between the reduction in the thickness of the middle retinal layer and increase in the amplitude of the b-waves and OPs suggest that the improvement of macular function after ERM peeling is due to the decrease in the thickness of the middle retinal layer.

Entities:  

Keywords:  focal macular electroretinograms; idiopathic epiretinal membrane; optical coherence tomography

Mesh:

Year:  2013        PMID: 24106117     DOI: 10.1167/iovs.13-12884

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Authors:  Shinji Ueno; Ayami Nakanishi; Kayo Nishi; Shiro Suzuki; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2014-11-13       Impact factor: 2.379

2.  Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.

Authors:  Tomoharu Nishimura; Shigeki Machida; Atsushi Tada; Eiki Oshida; Tetsuya Muto
Journal:  Doc Ophthalmol       Date:  2019-04-12       Impact factor: 2.379

3.  Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms.

Authors:  Kazuhiro Oiwa; Keiko Kataoka; Ruka Maruko; Shinji Ueno; Yasuki Ito; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2017-02-02       Impact factor: 2.447

4.  Role of ganglion cell complex in visual recovery following surgical internal limiting membrane peeling.

Authors:  Luisa Pierro; Lorenzo Iuliano; Marco Gagliardi; Marco Codenotti; Alessandro Ambrosi; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-23       Impact factor: 3.117

5.  Increase in electroretinogram rod-driven peak frequency of oscillatory potentials and dark-adapted responses in a cohort of myopia patients.

Authors:  Wenjuan Wan; Zihe Chen; Bo Lei
Journal:  Doc Ophthalmol       Date:  2019-10-28       Impact factor: 2.379

Review 6.  Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography.

Authors:  Yuji Itoh; Peter K Kaiser; Rishi P Singh; Sunil K Srivastava; Justis P Ehlers
Journal:  Ophthalmology       Date:  2014-09-07       Impact factor: 12.079

7.  SQUARE GRID DEFORMATION ANALYSIS OF THE MACULA AND POSTOPERATIVE METAMORPHOPSIA AFTER MACULAR HOLE SURGERY.

Authors:  Sun Ho Park; Keun Heung Park; Hwa Yeong Kim; Jae Jung Lee; Han Jo Kwon; Sung Who Park; Ik Soo Byon; Ji Eun Lee
Journal:  Retina       Date:  2021-05-01       Impact factor: 3.975

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.